Sandra Levy
ARTICLES BY THIS AUTHOR
- 11/7/2019
Schnucks expands curbside pickup to 59 stores
Schnucks’ curbside pickup service is now available at stores across Missouri, Illinois, and Indiana. - 11/7/2019
CVS to close 22 underperforming stores in first quarter 2020
In an SEC filing on Nov. 6, CVS signaled its intention to close 22 underperforming retail pharmacy stores in the first quarter of 2020. - 11/6/2019
Teva, Celltrion launch their Rituxan biosimilar Truxima
Teva and Celltrion's Truxima is the first biosimilar to Genentech’s Rituxan (rituximab). - 11/6/2019
Hy-Vee to honor veterans with free breakfast, events
On Nov. 11, more than 90,000 meals are expected to be provided to veterans and active-duty military at more than 265 Hy-Vee stores. - 11/6/2019
Cardinal Health posts revenue growth in Q1
Cardinal Health’s first-quarter revenue was $33.4 billion. Despite being 6% greater than revenue in the same quarter last year, it was accompanied by a 3% drop in profit. - 11/6/2019
Mallinckrodt completes sale of BioVectra for up to $250M
The terms of Mallinckrodt's sale of BioVBectra were updated since it was initially announced, with the final total at nearly $250 million. - 11/5/2019
RedHill Biopharma gets FDA green light for Talicia
RedHill's Talicia is the first and only FDA approved rifabutin-based H. pylori infection therapy. - 11/4/2019
Sandoz gets FDA green light for Neulasta biosimilar Ziextenzo
With the FDA approval of Ziextenzo — a biosimilar of Neulasta — Sandoz is the first and only company to offer long- and short-acting filgrastim biosimilar treatment options. - 11/4/2019
FDA approves Sanofi’s Fluzone High Dose Quadrivalent
Sanofi’s Fluzone High-Dose Quadrivalent is used in people age 65 and older, to protect against influenza A and B strains.
